Ping Jiang

4.7k total citations · 2 hit papers
133 papers, 3.4k citations indexed

About

Ping Jiang is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ping Jiang has authored 133 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Surgery, 30 papers in Cardiology and Cardiovascular Medicine and 24 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ping Jiang's work include Acute Myocardial Infarction Research (22 papers), Coronary Interventions and Diagnostics (18 papers) and Cardiac Imaging and Diagnostics (10 papers). Ping Jiang is often cited by papers focused on Acute Myocardial Infarction Research (22 papers), Coronary Interventions and Diagnostics (18 papers) and Cardiac Imaging and Diagnostics (10 papers). Ping Jiang collaborates with scholars based in China, United States and United Kingdom. Ping Jiang's co-authors include H. Michael Shepard, Sunil R. Hingorani, William Proctor Harris, Chao Sima, Janine LoBello, Caroline H. Diep, Daniel D. Von Hoff, Haiyong Han, Clifford J. Whatcott and Galen Hostetter and has published in prestigious journals such as Journal of Clinical Oncology, Journal of the American College of Cardiology and Cancer Research.

In The Last Decade

Ping Jiang

129 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Desmoplasia in Primary Tumors and Metastatic Lesions of Pancreatic Cancer

2015 469 citations Clifford J. Whatcott, Caroline H. Diep et al. Clinical Cancer Research profile →
HALO 202: Randomized Phase II Study of PEGPH20 Plus Nab-Paclitaxel/Gemcitabine Versus Nab-Paclitaxel/Gemcitabine in Patients With Untreated, Metastatic Pancreatic Ductal Adenocarcinoma

2017 365 citations Sunil R. Hingorani, Lei Zheng et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Ping Jiang

Since Specialization

Citations

This map shows the geographic impact of Ping Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ping Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ping Jiang more than expected).

Fields of papers citing papers by Ping Jiang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ping Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ping Jiang. The network helps show where Ping Jiang may publish in the future.

Co-authorship network of co-authors of Ping Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Ping Jiang. A scholar is included among the top collaborators of Ping Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ping Jiang. Ping Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	PEX5 deficiency enhances radiosensitivity via MGST1-GSH detoxifying function and promotes ferroptosis in liver cancer 2025 ·Science China Life Sciences ·(unknown), Tong Liu, Ping Jiang, Yang Zhao, (unknown), (unknown), Qiang He, Hao Wang, Lixiang Xue, Junjie Wang	1
2	Neutrophil-and-monocyte-to-lymphocyte ratio is positively associated with elevated prostate-specific antigen levels and high-risk prostate cancer: evidence from the NHANES (2003–2008) 2025 ·Frontiers in Cell and Developmental Biology ·(unknown), Ping Jiang, (unknown)	1
3	Discovery and analysis of the relationship between organic components in exhaled breath and bronchiectasis 2024 ·Journal of Breath Research ·Lichao Fan, (unknown), (unknown), (unknown), Shuo Liang, Kebin Cheng, Y. P. Pei, (unknown), Qingyun Li, (unknown), Ping Jiang, Haibin Chen, (unknown)	2
4	Circulating free DNA as a diagnostic marker for echinococcosis: a systematic review and meta-analysis 2024 ·Frontiers in Microbiology ·(unknown), Ping Jiang, Jideng Ma, Zi‐An Li, (unknown), Xiaoxing Wei, (unknown), (unknown), (unknown), Cheng Peng, (unknown), (unknown)	2
5	Role of serum B-cell-activating factor and interleukin-17 as biomarkers in the classification of interstitial pneumonia with autoimmune features 2024 ·Open Life Sciences ·Lihong Zhao, Li Liu, (unknown), (unknown), Ping Jiang	1
6	Effect of prior stroke on long‐term outcomes of percutaneous coronary interventions in Chinese patients: A large single‐center study 2018 ·Catheterization and Cardiovascular Interventions ·Jingjing Xu, Ying Song, Ping Jiang, Zhan Gao, Jianxin Li, Jue Chen, Yuejin Yang, Runlin Gao, Bo Xu, Jinqing Yuan	2
7	[Relationship between thrombolysis in myocardial infarction risk index and the severity of coronary artery lesions and long-term outcome in acute myocardial infarction patients undergoing percutaneous coronary intervention]. 2018 ·PubMed ·(unknown), Yaoming Song, Junfeng Xu, Xiaonan Tang, (unknown), Ping Jiang, (unknown), (unknown), (unknown), (unknown), Li Song, (unknown), (unknown), Zhan Gao, Shubin Qiao, (unknown), (unknown), Bo Xu, (unknown)	2
8	Impact of Residual SYNTAX Score and Its Derived Indexes on Clinical Outcomes after Percutaneous Coronary Intervention 2018 ·Chinese Medical Journal ·Ying Song, Zhan Gao, Xiaofang Tang, Ping Jiang, Jingjing Xu, Yi Yao, Jianxin Li, Xueyan Zhao, Shubin Qiao, Yuejin Yang, (unknown), Bo Xu, Jinqing Yuan	4
9	Viral infection in community acquired pneumonia patients with fever: a prospective observational study 2018 ·Journal of Thoracic Disease ·(unknown), (unknown), (unknown), Bei Mao, (unknown), (unknown), Li Yu, (unknown), Shuo Liang, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Ping Jiang, (unknown), Jin‐Fu Xu	33
10	HALO 202: Randomized Phase II Study of PEGPH20 Plus Nab-Paclitaxel/Gemcitabine Versus Nab-Paclitaxel/Gemcitabine in Patients With Untreated, Metastatic Pancreatic Ductal Adenocarcinoma breakdown → 2017 ·Journal of Clinical Oncology ·Sunil R. Hingorani, Lei Zheng, Andrea J. Bullock, Tara Elisabeth Seery, William Proctor Harris, Darren Sigal, Fadi Braiteh, Paul S. Ritch, Mark M. Zalupski, Nathan Bahary, Paul E. Oberstein, Andrea Wang‐Gillam, Wilson Wu, Dimitrios Chondros, Ping Jiang, Sihem Khelifa, Jie Pu, Carrie Aldrich, Andrew Hendifar	365
11	Identification of plasma biomarkers for distinguishing bipolar depression from major depressive disorder by iTRAQ-coupled LC–MS/MS and bioinformatics analysis 2017 ·Psychoneuroendocrinology ·Juanjuan Ren, Guoqing Zhao, (unknown), Hongmei Liu, Ping Jiang, Jun Chen, Zhiguo Wu, Daihui Peng, Yiru Fang, Chen Zhang	51
12	Phase Ib Study of PEGylated Recombinant Human Hyaluronidase and Gemcitabine in Patients with Advanced Pancreatic Cancer 2016 ·Clinical Cancer Research ·Sunil R. Hingorani, William Proctor Harris, J. Thaddeus Beck, Б. А. Бердов, Stephanie A. Wagner, (unknown), Sergei Tjulandin, Oleg Gladkov, Randall F. Holcombe, Ronald L. Korn, Natarajan Raghunand, Samuel S. Dychter, Ping Jiang, H. Michael Shepard, Craig Devoe	262
13	The effects of TaiChiquan on pulmonary rehabilitation for patients with stable chronic obstructive pulmonary disease 2016 ·(unknown), Hong Chen, Zhibo Xu, Ping Jiang, Yuejun Du, Lei Song, (unknown)	2
14	PD-006 Final analysis of stage 1 data from a randomized phase 2 study of PEGPH20 plus nab-paclitaxel/gemcitabine in stage IV previously untreated pancreatic cancer patients, utilizing Ventana companion diagnostic assay 2016 ·Annals of Oncology ·Sunil R. Hingorani, Andrea J. Bullock, William Proctor Harris, Wilson Wu, Ping Jiang, Dimitrios Chondros, Sihem Khelifa, Carrie Aldrich, Jeffrey J. Pu, Andrew Hendifar	1
15	Desmoplasia in Primary Tumors and Metastatic Lesions of Pancreatic Cancer breakdown → 2015 ·Clinical Cancer Research ·Clifford J. Whatcott, Caroline H. Diep, Ping Jiang, Aprill Watanabe, Janine LoBello, Chao Sima, Galen Hostetter, H. Michael Shepard, Daniel D. Von Hoff, Haiyong Han	469
16	Phase 1 studies of anti-interleukin-1 dual-variable domain immunoglobulin in healthy subjects and patients with osteoarthritis 2015 ·Osteoarthritis and Cartilage ·(unknown), (unknown), Ping Jiang, Martin M. Okun, Richard A. Preston, Carlos J. Lozada, (unknown), Jan Paul Medema	2
17	Judging disease activity in rheumatoid arthritis by serum free kappa and lambda light chain levels 2013 ·The Kaohsiung Journal of Medical Sciences ·Yun Ye, (unknown), (unknown), Ping Jiang, Kaige Liu, Yajun Li	16
18	Two-year prognostic value of mean platelet volume in patients with diabetes and stable coronary artery disease undergoing elective percutaneous coronary intervention 2013 ·Cardiology Journal ·Ping Jiang, Ying Song, Jingjing Xu, Huanhuan Wang, Lin Jiang, Wei Zhao, Xueyan Zhao, Jue Chen, Zhan Gao, Shubin Qiao, Yuejin Yang, Runlin Gao, Bo Xu, Jinqing Yuan	11
19	Flushing ASsessment Tool (FAST©) 2009 ·Clinical Drug Investigation ·Ariane K. Kawata, Dennis A. Revicki, Roopal Thakkar, Ping Jiang, Scott Krause, Michael H. Davidson, Henry Punzi, Robert J. Padley	18
20	In vitro permeability of round window membrane to transforming dexamethasone with delivery vehicles — a dosage estimation 2007 ·Chinese Medical Journal ·(unknown), Liu Ya, Weijia Kong, Ping Jiang, Wei Jiang	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact